Sean F. Scanlan, Chief Innovation Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 25,000 shares at $25.57 ($639K) on 2023-01-12, disclosed to the SEC on 2023-01-13.
Open-market sale of $639k TMCI by Chief Innovation Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMCI | SELL | 2023-03-10 | $12K | — | Filing → |
| TMCI | SELL | 2023-02-17 | $542K | — | Filing → |
| TMCI | SELL | 2022-11-16 | $607K | — | Filing → |